PTPRC Protein — Protein Tyrosine Phosphatase Receptor Type C (CD45)
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">PTPRC Protein (CD45)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Protein Tyrosine Phosphatase Receptor Type C</td></tr>
<tr><td><strong>Gene</strong></td><td>[PTPRC](/genes/ptprc)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P08575](https://www.uniprot.org/uniprot/P08575)</td></tr>
<tr><td><strong>PDB ID</strong></td><td>5ln3, 5cms, 1YJ2</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>180-220 kDa (various isoforms)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cell membrane (type I transmembrane)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Receptor-type PTP family (CD45 family)</td></tr>
<tr><td><strong>Expression</strong></td><td>All nucleated hematopoietic cells, microglia</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">6 edges</a></td>
</tr>
</table>
</div>
Overview
PTPRC (Protein Tyrosine Phosphatase Receptor Type C), more commonly known as CD45, is a receptor-type protein tyrosine phosphatase that plays a central role in regulating immune cell signaling[@thomas1992]. As the prototypic member of the CD45 family, CD45 is expressed on all nucleated hematopoietic cells and serves as a critical regulator of signal transduction thresholds in immune cells. In the central nervous system, CD45 is expressed primarily on microglia, the resident immune cells of the brain, where it plays essential roles in modulating neuroinflammatory responses and microglial activation states[@wyss-coray2013].
CD45 is a large transmembrane protein characterized by an heavily glycosylated extracellular domain, a single transmembrane helix, and an intracellular tyrosine phosphatase domain. The protein undergoes extensive alternative splicing, generating multiple isoforms with distinct functions and tissue distributions. This complexity allows CD45 to finetune immune responses in different contexts, including within the brain where microglial CD45 critically influences neurodegenerative disease progression[@butters2003].
This comprehensive page covers CD45's molecular structure, its normal functions in the nervous system, its dysregulation in neurodegenerative diseases, and its potential as a therapeutic target.
Structure and Molecular Architecture
CD45 possesses a distinctive multi-domain architecture that enables its unique regulatory functions:
Domain Organization
Mermaid diagram (expand to render)
Extracellular Domain (aa 1-583):
- Heavily O-glycosylated with multiple N-linked glycans
- Contains a variable region subject to alternative splicing
- Includes three fibronectin-type III repeats
- Determines isoform-specific functions
Transmembrane Region (aa 584-606):
- Single alpha-helical transmembrane segment
- Anchors CD45 to the plasma membrane
- Couples extracellular signals to intracellular responses
Intracellular Domain (aa 607-1284):
- Contains tandem phosphatase domains
- The membrane-proximal domain (D1) is catalytically active
- The membrane-distal domain (D2) is regulatory
- Multiple phosphorylation sites for regulation
CD45 exists in multiple isoforms generated by alternative splicing:
CD45RO: Short isoform lacking exons 4-6 (extracellular domain)
- Expressed on activated and memory T cells
- Common in inflammatory conditions
CD45RA: Long isoform including all exons
- Expressed on naive T cells
- Used as T cell maturation marker
CD45RB: Intermediate isoform
- B cell and macrophage expression
- Common in brain microglia
CD45RC: Variable isoform
- T and B cell specific expression
Post-translational Modifications
Glycosylation:
- Extensive O-linked glycosylation in extracellular domain
- N-linked glycosylation sites
- Sialylation affects ligand interactions
Phosphorylation:
- Tyrosine phosphorylation regulates activity
- Serine/threonine phosphorylation modulates function
- Kinase/phosphatase dynamics control signaling
Normal Physiological Functions
Immune Cell Signaling
CD45 is a master regulator of immune cell signal transduction:
Src Family Kinase Regulation:
- Dephosphorylates inhibitory tyrosine residues on Src family kinases
- Activates LCK, FYN, LYN in T cells
- Modulates signal intensity through BCR and TCR[@hermiston2001]
Signal Threshold Setting:
- Determines the sensitivity of immune cells to stimuli
- Prevents spontaneous activation
- Enables appropriate response to antigens
Cellular Activation:
- Controls activation and differentiation outcomes
- Regulates cytokine production
- Modulates proliferation
Microglial Function
In the brain, CD45 performs critical microglial regulatory functions:
Activation State Modulation:
- Regulates microglial activation states
- Controls pro-inflammatory vs. anti-inflammatory phenotypes
- Influences phagocytic activity[@schwartz2003]
Cytokine Regulation:
- Modulates cytokine production
- Controls chemokine expression
- Regulates inflammatory responses[@zhu2011]
Phagocytosis:
- Affects microglial phagocytosis of debris
- Regulates amyloid clearance
- Controls synaptic pruning
Role in Alzheimer's Disease
Microglial Dysfunction
CD45 plays a complex role in Alzheimer's disease pathogenesis:
Amyloid Clearance:
- CD45 deficiency enhances microglial amyloid clearance
- Reduced CD45 leads to improved Aβ removal
- Suggests CD45 may limit beneficial microglial responses[@tan2008]
Chronic Activation:
- Elevated CD45 in AD microglia
- Dysregulated signaling contributes to chronic inflammation
- May promote neurotoxicity
Expression Changes:
- Altered CD45 isoform expression in AD brain
- Changes correlate with disease severity
- Potential biomarker potential[@lalANC2010]
Pathological Mechanisms
Mermaid diagram (expand to render)
Neuroinflammation:
- CD45 drives pro-inflammatory microglial responses
- Contributes to chronic neuroinflammation
- Promotes cytokine-mediated toxicity
Synaptic Dysfunction:
- Microglial-mediated synapse loss
- Pruning dysregulation
- Contributes to cognitive decline
Therapeutic Implications:
- CD45 modulation could reduce harmful inflammation
- Could enhance beneficial microglial functions
- Potential for immunotherapy approaches["@liu2014"]
Role in Parkinson's Disease
Microglial Activation
CD45 is implicated in Parkinson's disease through microglial pathways:
Dopaminergic Neuron Vulnerability:
- Activated microglia with altered CD45 in substantia nigra
- Chronic inflammation contributes to neuron loss
- CD45-regulated cytokines affect survival[@zhang2019]
Inflammatory Responses:
- Elevated CD45 in PD brain
- Enhanced pro-inflammatory signaling
- Contributes to disease progression
Mitochondrial Connections:
- CD45 affects microglial mitochondrial function
- Altered energy metabolism in PD
- Potential therapeutic target
Expression Changes
- Increased CD45 expression in PD substantia nigra
- Correlation with disease severity
- Changes in CD45 isoforms
Role in Other Neurodegenerative Disorders
Amyotrophic Lateral Sclerosis
- Altered CD45 on microglia in ALS
- Contributes to motor neuron inflammation
- Potential therapeutic target
Multiple Sclerosis
- CD45 in demyelinating lesions
- Regulates autoimmune responses
- T cell regulation role
Huntington's Disease
- Microglial CD45 dysregulation
- Contributes to striatal degeneration
- Inflammatory component
Interaction Network
Immune Cell Signaling
| Partner Protein | Interaction Type | Functional Consequence |
|-----------------|-------------------|------------------------|
| LCK | Dephosphorylation | T cell activation |
| FYN | Dephosphorylation | Signal initiation |
| SYK | Dephosphorylation | B cell signaling |
| ZAP-70 | Dephosphorylation | TCR signaling |
Microglial Interactions
| Partner | Interaction | Effect |
|---------|-------------|--------|
| Tyrosine kinases | Regulation | Activation state |
| Cytokine receptors | Modulation | Inflammatory response |
| Phagocytic receptors | Coordination | Clearance function |
Animal Models
Knockout Studies
CD45 Knockout Mice:
- Severe combined immunodeficiency
- Impaired T and B cell development
- Altered immune responses
Conditional Knockouts:
- Microglial-specific knockouts reveal brain functions
- Neurological phenotypes
- Inflammation-related changes
Disease Models
- AD mouse models show CD45 involvement
- PD models demonstrate microglial CD45 role
- Therapeutic intervention studies
Therapeutic Implications
Targeting Strategies
Immunomodulation:
- CD45 antibodies for immune modulation
- Small molecule phosphatase modulators
- Cytokine pathway targeting[@liu2014]
Microglial Targeting:
- Modulating microglial activation states
- Enhancing beneficial functions
- Reducing harmful inflammation
Challenges
Specificity:
- CD45 is ubiquitously expressed
- Systemic effects possible
- Achieving brain specificity
Complexity:
- Multiple isoforms with different functions
- Context-dependent effects
- Balancing inflammation and immunity
Genetic Variation
Polymorphisms
- CD45 variants associated with autoimmune diseases
- Some variants may modify neurodegenerative disease risk
- Effect on protein expression and function[@chen2018]
Biomarker Potential
- CD45 as disease progression marker
- Cerebrospinal fluid CD45 measurements
- Imaging of microglial activation[@zhou2021]
Future Directions
Research Priorities
Isoform-Specific Functions: Understanding different CD45 isoforms
Cell-Type Specific Roles: Microglial vs. other immune cells
Therapeutic Development: Brain-penetrant CD45 modulators
Biomarker Studies: CD45 as disease biomarkerUnanswered Questions
- What is the precise role of CD45 in different disease stages?
- Can CD45 modulation achieve therapeutic benefits safely?
- What are the optimal biomarkers for patient selection?
See Also
- [PTPRC Gene](/genes/ptprc)
- [Microglial Activation](/mechanisms/microglial-activation)
- [Neuroinflammation](/mechanisms/neuroinflammation)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Immune Signaling](/mechanisms/immune-signaling)
- [Phagocytosis](/mechanisms/microglial-phagocytosis)
External Links
- [UniProt: PTPRC (P08575)](https://www.uniprot.org/uniprot/P08575)
- [NCBI Gene: PTPRC](https://www.ncbi.nlm.nih.gov/gene/5756)
- [PDB: CD45 Structures](https://www.rcsb.org/)
- [PubMed: CD45 Research](https://pubmed.ncbi.nlm.nih.gov/?term=CD45+neurodegeneration)